$6.47 Billion is the total value of Laurion Capital Management LP's 455 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| RXRX | RECURSION PHARMACEUTICALS INcl a | $37,341,000 | +13.7% | 4,587,274 | 0.0% | 0.58% | +43.5% | |
| EXSCIENTIA PLCads | $23,219,000 | -24.4% | 2,132,154 | 0.0% | 0.36% | -4.5% | ||
| AMD | ADVANCED MICRO DEVICES INCput | $20,647,000 | -30.1% | 270,000 | 0.0% | 0.32% | -11.6% | |
| ACRS | ACLARIS THERAPEUTICS INC | $20,103,000 | -19.0% | 1,440,075 | 0.0% | 0.31% | +2.0% | |
| CME | CME GROUP INC | $9,212,000 | -13.9% | 45,004 | 0.0% | 0.14% | +8.4% | |
| MDT | MEDTRONIC PLCcall | $8,975,000 | -19.1% | 100,000 | 0.0% | 0.14% | +2.2% | |
| KO | COCA COLA COput | $7,864,000 | +1.5% | 125,000 | 0.0% | 0.12% | +27.4% | |
| RACB | RESEARCH ALLIANCE CORP II | $7,840,000 | +0.4% | 800,000 | 0.0% | 0.12% | +26.0% | |
| CAT | CATERPILLAR INCput | $7,150,000 | -19.8% | 40,000 | 0.0% | 0.11% | +0.9% | |
| ACET | ADICET BIO INC | $6,446,000 | -26.9% | 441,518 | 0.0% | 0.10% | -7.4% | |
| KALV | KALVISTA PHARMACEUTICALS INC | $4,625,000 | -33.2% | 470,000 | 0.0% | 0.07% | -16.5% | |
| VOR | VOR BIOPHARMA INC | $4,261,000 | -17.7% | 857,308 | 0.0% | 0.07% | +4.8% | |
| ICOSAVAX INC | $4,254,000 | -18.6% | 742,354 | 0.0% | 0.07% | +3.1% | ||
| MBACU | M3 BRIGADE ACQUISITION II COunit 99/99/9999 | $3,920,000 | -0.3% | 400,000 | 0.0% | 0.06% | +27.1% | |
| LULU | LULULEMON ATHLETICA INC | $3,944,000 | -25.4% | 14,467 | 0.0% | 0.06% | -6.2% | |
| GHRS | GH RESEARCH PLCordinary shares | $3,143,000 | -45.4% | 314,930 | 0.0% | 0.05% | -30.0% | |
| TWO HARBORS INVENTMENT CORPOnote 6.250% 1/1 | $2,750,000 | -7.4% | 3,000,000 | 0.0% | 0.04% | +16.7% | ||
| TRICIDA INCnote 3.500% 5/1 | $2,430,000 | +10.0% | 4,500,000 | 0.0% | 0.04% | +40.7% | ||
| CMPS | COMPASS PATHWAYS PLCsponsored ads | $2,049,000 | -16.1% | 189,407 | 0.0% | 0.03% | +6.7% | |
| FDMT | 4D MOLECULAR THERAPEUTICS IN | $1,711,000 | -53.8% | 245,123 | 0.0% | 0.03% | -42.2% | |
| TRAVERE THERAPEUTICS INCnote 2.250% 3/0 | $1,500,000 | -5.7% | 1,500,000 | 0.0% | 0.02% | +21.1% | ||
| IACC | ION ACQUISITION CORP 3 LTD | $1,463,000 | +0.1% | 150,000 | 0.0% | 0.02% | +27.8% | |
| TALS | TALARIS THERAPEUTICS INC | $1,346,000 | -54.2% | 298,422 | 0.0% | 0.02% | -41.7% | |
| THESEUS PHARMACEUTICALS INC | $994,000 | -52.0% | 179,619 | 0.0% | 0.02% | -40.0% | ||
| VALN | VALNEVA SEsponsored ads | $568,000 | -33.2% | 25,000 | 0.0% | 0.01% | -10.0% | |
| TBLA | TABOOLA.COM LTD | $506,000 | -51.0% | 200,000 | 0.0% | 0.01% | -38.5% | |
| FACT | FREEDOM ACQUISITION I CORP | $491,000 | +0.2% | 50,000 | 0.0% | 0.01% | +33.3% | |
| DMY TECHNOLOGY GROUP INC VI | $489,000 | -1.0% | 50,000 | 0.0% | 0.01% | +33.3% | ||
| FLAC | FRAZIER LIFESCIENCES ACQU CO | $494,000 | +0.6% | 50,000 | 0.0% | 0.01% | +33.3% | |
| IONQ INC | $438,000 | -65.7% | 100,000 | 0.0% | 0.01% | -56.2% | ||
| CORSAIR PARTNERING CORP | $484,000 | -0.4% | 50,000 | 0.0% | 0.01% | +16.7% | ||
| INNOVID CORP | $482,000 | -72.5% | 290,305 | 0.0% | 0.01% | -66.7% | ||
| GLTO | GALECTO INC | $330,000 | -21.2% | 190,652 | 0.0% | 0.01% | 0.0% | |
| NDAC | NIGHTDRAGON ACQUISITION CORP | $195,000 | 0.0% | 20,000 | 0.0% | 0.00% | +50.0% | |
| FNCH | FINCH THERAPEUTICS GROUP INC | $165,000 | -43.5% | 58,000 | 0.0% | 0.00% | -25.0% | |
| TBCP | THUNDER BRIDGE CAP PRTNRS II | $196,000 | 0.0% | 20,000 | 0.0% | 0.00% | +50.0% | |
| SCLE | BROADSCALE ACQUISITION CORP | $196,000 | -0.5% | 20,000 | 0.0% | 0.00% | +50.0% | |
| GSEV | GORES HOLDINGS VII INC | $98,000 | 0.0% | 10,000 | 0.0% | 0.00% | +100.0% | |
| LBPH | LONGBOARD PHARMACEUTICALS IN | $65,000 | -40.4% | 20,918 | 0.0% | 0.00% | 0.0% | |
| DBTX | DECIBEL THERAPEUTICS INC | $50,000 | +38.9% | 11,990 | 0.0% | 0.00% | – | |
| DMY TECHNOLOGY GROUP INC VI*w exp 99/99/999 | $9,000 | -47.1% | 25,000 | 0.0% | 0.00% | – | ||
| INNOVID CORP*w exp 11/30/202 | $6,000 | -76.0% | 25,000 | 0.0% | 0.00% | – | ||
| RIGETTI COMPUTING INC*w exp 99/99/999 | $6,000 | -53.8% | 10,000 | 0.0% | 0.00% | – | ||
| IONQ INC*w exp 99/99/999 | $21,000 | -78.6% | 25,000 | 0.0% | 0.00% | -100.0% | ||
| TBLAW | TABOOLA.COM LTD*w exp 06/29/202 | $30,000 | -64.7% | 85,000 | 0.0% | 0.00% | -100.0% | |
| FACTWS | FREEDOM ACQUISITION I CORP*w exp 99/99/999 | $3,000 | -40.0% | 12,500 | 0.0% | 0.00% | – | |
| CORSAIR PARTNERING CORP*w exp 07/06/202 | $3,000 | -57.1% | 16,666 | 0.0% | 0.00% | – | ||
| FLACW | FRAZIER LIFESCIENCES ACQU CO*w exp 11/30/202 | $1,000 | -75.0% | 16,666 | 0.0% | 0.00% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-08-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CME GROUP INC | 42 | Q3 2023 | 0.2% |
| CITIGROUP INC | 40 | Q3 2023 | 5.1% |
| CITIGROUP INC | 40 | Q3 2023 | 3.9% |
| MORGAN STANLEY | 39 | Q3 2023 | 1.3% |
| APPLE INC | 38 | Q3 2023 | 6.4% |
| JPMORGAN CHASE & CO | 38 | Q3 2023 | 3.6% |
| BK OF AMERICA CORP | 38 | Q3 2023 | 2.1% |
| JPMORGAN CHASE & CO | 38 | Q3 2023 | 2.3% |
| APPLE INC | 37 | Q3 2023 | 6.2% |
| BK OF AMERICA CORP | 37 | Q3 2023 | 2.2% |
View Laurion Capital Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Codiak BioSciences, Inc. | March 03, 2023 | 3,713,300 | 9.6% |
| Pyxis Oncology, Inc. | February 08, 2023 | 3,170,803 | 9.0% |
| Research Alliance Corp. II | February 08, 2023 | ? | ? |
View Laurion Capital Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G | 2024-02-08 |
| SC 13G | 2024-02-08 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13G/A | 2023-03-03 |
| 13F-HR | 2023-02-14 |
| SC 13G/A | 2023-02-08 |
| SC 13G | 2023-02-08 |
View Laurion Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.